
Waydif SP 50mg/325mg/10mg Tablet
Manufacturer
Waylone Healthcare Pvt Ltd
Salt Composition
Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Key Information
Short Description
Waydif SP 50mg/325mg/10mg Tablet is a pain-relieving medicine that helps in relieving moderate pain and reducing fever.
Dosage Form
Tablet
Introduction
Waydif SP 50mg/325mg/10mg Tablet should be taken with food. This will prevent you from getting an upset stomach. The dose and duration will depend on what you are taking it for and how well it helps your symptoms. You should keep taking the medicine even if you feel better until the doctor says it is alright to stop using it.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Waydif SP 50mg/325mg/10mg Tablet is to be taken with food.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Waydif SP 50mg/325mg/10mg Tablet.
Breastfeeding Warning
Information regarding the use of Waydif SP 50mg/325mg/10mg Tablet during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Waydif SP 50mg/325mg/10mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
How it works
Waydif SP 50mg/325mg/10mg Tablet is a combination of three medicines: Diclofenac, Paracetamol and Serratiopeptidase. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation and promotes healing.
Quick Tips
You have been prescribed this combination medicine for relieving pain and inflammation. Take it with food to avoid getting an upset stomach. It may cause dizziness and sleepiness. Do not drive or do anything that requires mental focus until you know how Waydif SP 50mg/325mg/10mg Tablet affects you. Avoid consuming alcohol when taking Waydif SP 50mg/325mg/10mg Tablet as it may cause excessive drowsiness and increase the risk of liver damage. Do not take it with any other medicine containing acetaminophen (drugs for pain/fever or cough-and-cold) without asking your doctor first.
Related Medicines

Ebility Tablet

Lyser DP Tablet

Zinase-DP Tablet

Stendase SP 50mg/325mg/10mg Tablet

Goldpar SP 50mg/325mg/10mg Tablet

Dicmak SP 50mg/325mg/10mg Tablet

Adine-Plus Tablet

Eramol SP 50mg/325mg/10mg Tablet

Recoflam-SP Tablet

Espidase DP Tablet
Frequently asked questions
What are the proper storage conditions for Waydif SP 50mg/325mg/10mg Tablet?
Store this medicine in its original container, tightly closed. Follow the storage instructions provided on the pack or label. Dispose of any unused medication and ensure it is not accessible to pets, children, or other individuals.
What is Waydif SP 50mg/325mg/10mg Tablet?
Waydif SP 50mg/325mg/10mg Tablet is a combination medication consisting of diclofenac, paracetamol, and serratiopeptidase. It helps to relieve pain and inflammation by reducing the levels of chemical substances in the body that cause these symptoms.
Is Waydif SP 50mg/325mg/10mg Tablet safe for most patients?
Yes, Waydif SP 50mg/325mg/10mg Tablet is generally safe for most patients. However, some individuals may experience common side effects such as nausea, vomiting, stomach pain, heartburn, and diarrhea. If you experience any persistent problems due to the medication, inform your doctor immediately.
Can I stop taking Waydif SP 50mg/325mg/10mg Tablet when my pain is relieved?
Typically, Waydif SP 50mg/325mg/10mg Tablet is used for a short term and can be discontinued once the pain is relieved. However, if you are advised by your physician to continue taking the medication, do so.
Can the use of Waydif SP 50mg/325mg/10mg Tablet cause nausea and vomiting?
Yes, using Waydif SP 50mg/325mg/10mg Tablet can lead to nausea and vomiting. Taking it with milk, food, or antacids may help prevent nausea. Avoid consuming fatty or fried foods along with this medication. If you experience persistent vomiting and notice signs of dehydration, such as dark-colored and strong-smelling urine and a low frequency of urination, talk to your doctor.
Can the use of Waydif SP 50mg/325mg/10mg Tablet cause dizziness?
Yes, using Waydif SP 50mg/325mg/10mg Tablet can cause dizziness in some patients. If you feel dizzy or lightheaded, it is recommended to rest for a while and resume once you feel better. Avoid driving or operating machinery.
Are there any specific contraindications associated with the use of Waydif SP 50mg/325mg/10mg Tablet?
The use of Waydif SP 50mg/325mg/10mg Tablet is considered harmful for patients with known allergies to any of its components or excipients, as well as those with a history of stomach ulcers or active bleeding. It should also be avoided in patients with a history of heart failure, high blood pressure, and liver or kidney disease.
Can I take Waydif SP 50mg/325mg/10mg Tablet with Vitamin B-complex?
Yes, you can take Waydif SP 50mg/325mg/10mg Tablet with Vitamin B-complex preparations. While the medication helps to relieve pain, the vitamin can help correct any underlying nutritional deficiencies contributing to your symptoms.
Can I take Waydif SP 50mg/325mg/10mg Tablet for stomach pain?
No, it is not recommended to take Waydif SP 50mg/325mg/10mg Tablet for stomach pain without consulting a physician. This medication can increase stomach acid secretion and may exacerbate an underlying condition.
Can the use of Waydif SP 50mg/325mg/10mg Tablet cause damage to kidneys?
No, taking higher than recommended doses of Waydif SP 50mg/325mg/10mg Tablet increases the risk of side effects. If you experience severe pain or if your pain is not relieved by the recommended doses, consult your doctor for re-evaluation.